يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Neoplasms::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms::Carcinoma, Renal Cell [DISEASES]"', وقت الاستعلام: 0.79s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, [Motzer RJ] Memorial Sloan Kettering Cancer Center, New York, NY, USA. [Schmidinger M] Medical University of Vienna, Vienna, Austria. [Eto M] Kyushu University Hospital, Fukuoka, Japan. [Suarez C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Figlin R] Cedars-Sinai Medical Center, Los Angeles, CA, USA. [Liu Y] Merck & Co., Inc., Rahway, NJ, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  2. 2

    المساهمون: Institut Català de la Salut, [McGregor B] Dana-Farber Cancer Institute, Boston, MA, USA. [Geynisman DM] Fox Chase Cancer Center, Philadelphia, PA, USA. [Burotto M] Bradford Hill Clinical Research Center, Santiago, Chile. [Porta C] University of Bari 'A. Moro,' and Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy. [Suarez C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Bourlon MT] Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  3. 3

    المساهمون: Institut Català de la Salut, [Suarez C, Marmolejo D, Valdivia A, Morales-Barrera R, Gonzalez M, Mateo J, Carles J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Semidey ME] Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Lorente D, Trilla E] Servei d'Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  4. 4

    المساهمون: Institut Català de la Salut, [Navani V, Ernst M] Tom Baker Cancer Centre, Department of Medical Oncology, University of Calgary, Calgary, Canada. [Wells JC] BC Cancer Agency, Vancouver, Canada. [Yuasa T] Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. [Takemura K] Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. [Donskov F] Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. [Suarez C] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Navani, V, Ernst, M, Wells, J C, Yuasa, T, Takemura, K, Donskov, F, Basappa, N S, Schmidt, A, Pal, S K, Meza, L, Wood, L A, Ernst, D S, Szabados, B, Powles, T, McKay, R R, Weickhardt, A, Suarez, C, Kapoor, A, Lee, J L, Choueiri, T K & Heng, D Y C 2022, ' Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients with Metastatic Renal Cell Carcinoma ', JAMA network open, vol. 5, no. 6, pp. E2216379 . https://doi.org/10.1001/jamanetworkopen.2022.16379

    وصف الملف: application/pdf

  5. 5

    المساهمون: Institut Català de la Salut, [Geynisman DM] Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA. [Burotto M] Oncology Department, Bradford Hill Clinical Research Center, Santiago, Chile. [Porta C] Interdisciplinary Department of Medicine, University of Bari ‘A.Moro’ and Division of Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy. [Suarez C] Servei d’Oncologia Mèdica, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Bourlon MT] Department of Hemato-Oncology, Urologic Oncology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. [Huo S] Worldwide Health Economics and Outcomes Research-US Market, Bristol Myers Squibb, Princeton, NJ, USA, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

  6. 6

    المساهمون: Institut Català de la Salut, [Grande E] Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain. [Alonso-Gordoa T] Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Reig O] Medical Oncology, Hospital Clinic and Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. [Esteban E] Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. [Castellano D] Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. [Garcia-Del-Muro X] Medical Oncology, Institut Català d’Oncologia (ICO Bellvitge) Idibell, University of Barcelona, Barcelona, Spain. [González Rodríguez M] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de la UB
    Universidad de Barcelona
    Scientia

    مصطلحات موضوعية: Male, Cancer Research, Indoles, compuestos heterocíclicos::compuestos heterocíclicos con anillos de fusión::compuestos heterocíclicos de 2 anillos::indoles [COMPUESTOS QUÍMICOS Y DROGAS], sunitinib, neoplasias::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias renales::carcinoma de células renales [ENFERMEDADES], Ronyons - Càncer - Tractamemt, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Càncer de ronyó, immune checkpoint inhibitors, Sunitinib, Humans, Prospective Studies, Other subheadings::/therapeutic use [Other subheadings], Carcinoma, Renal Cell, Otros calificadores::/uso terapéutico [Otros calificadores], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Enzyme inhibitors, metastatic renal carcinoma, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Kidney Neoplasms, Renal cancer, Oncology, Inhibidors enzimàtics, second-line treatment, Neoplasms::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms::Carcinoma, Renal Cell [DISEASES], Avaluació de resultats (Assistència sanitària), Female, Heterocyclic Compounds::Heterocyclic Compounds, Fused-Ring::Heterocyclic Compounds, 2-Ring::Indoles [CHEMICALS AND DRUGS]

    وصف الملف: application/pdf

  7. 7

    المساهمون: Institut Català de la Salut, [Arévalo J] Grup de CIBBIM-Nanomedicina. Fisiopatología renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Lorente D, Trilla E, Morote J] Servei d’Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Salcedo MT] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Meseguer A] CIBBIM-Nanomedicina. Fisiopatología renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    Scientia
    Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
    Scientific Reports

    وصف الملف: application/pdf